Patients-specific prompts in the cholesterol management of renal transplant outpatients: Results and analysis of underperformance

Transplantation

Volumn 78, Issue 7, 2004, Pages 1042-1047

  Garthwaite, Elizabeth A ^a,b   Will, Eric J ^a   Bartlett, Cherry ^a   Richardson, Donald ^b   Newstead, Charles G ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cardiovascular disease; Hypercholesterolemia; Renal transplantation

Indexed keywords

ALKALINE PHOSPHATASE; ATORVASTATIN; CHOLESTEROL; CREATINE KINASE; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STATINE DERIVATIVE;

ADULT; AGE; ALGORITHM; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPUTER PROGRAM; CREATINE KINASE BLOOD LEVEL; CREATININE CLEARANCE; DECISION SUPPORT SYSTEM; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; SIDE EFFECT; BLOOD; COMPUTER AIDED DESIGN; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; CHOLESTEROL; COMPUTER-AIDED DESIGN; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 6344245655     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000137340.22880.C8     Document Type: Article

References (18)

1. Aakus S, Dabl K, Wideroe T. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transpl 1999; 14: 648-654.
2. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 5963 people with diabetes: a randomised placebo controlled trial. Lancet 2003; 361: 2005-2016.
3. Crouse J, Byington RP, Furberg CD. HMG CoA reductase inhibitor therapy and stroke risk reduction; an analysis of clinical trials data. Atherosclerosis 1998; 138: 11-24.
4. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307.
5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
6. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009.
7. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-1357.
8. Athyros VG, Papageorgiou AA, Mercouris BR, et al. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The Greek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin 2002; 18: 220-228.
9. Aakhus S, Dahl K, Wideroe TE. Hyperlipidaemia in renal transplant patients. J Intern Med 1996; 239: 407-415.
10. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260-269.
11. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333: 621-627.
12. Holdaas H, Jardine AG, Wheeler DC, et al. Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial. Kidney Int 2001; 60: 1990-1997.
13. Hunt DL, Haynes RB, Hanna SE, et al. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA 1998; 280: 1339-1346.
14. Eccles M, McColl E, Steen N, et al. Effect of computerised evidence based guidelines on management of asthma and angina in adults in primary care: cluster randomised controlled trial. BMJ 2002; 325: 941.
15. Ansell D, Burden R, Feest T, et al. United Kingdom Renal Registry Report. 2001. United Kingdom Renal Registry, Bristol, UK.
16. Grimshaw J, Freemantle N, Wallace S, et al. Developing and implementing clinical practice guidelines. Qual Health Care 1995; 4: 55-64.
17. Will E. Targets and targeting. Am J Kidney Dis 2001; 38: 411-414.
18. Holdaas H, Fellstrom B, Jardine AG, et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 2003; 361: 2024-2031.